n-SMase2, encoded by SMPD3, catalyzes SM catabolism to produce the anti-tumor metabolite Cer, and is associated with early postoperative recurrence of hepatocellular carcinoma [115]. This evidence concerns the gene SMPD3 and hepatocellular carcinoma.